|
Product cited in:
|
Stax, Gelderman, Kamerling, van der Geest, Schlagwein, van Kooten: "Generation and characterization of a novel anti-rat CD40L antibody with inhibitory activities in vitro and in vivo." in: Journal of immunological methods, Vol. 335, Issue 1-2, pp. 46-52, 2008 (PubMed).
Henn, Steinbach, Büchner, Presek, Kroczek: "The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40." in: Blood, Vol. 98, Issue 4, pp. 1047-54, 2001 (PubMed).
Tong, Papayoti, Netto, Armstrong, Ordonez, Lawson, Stone: "Growth-inhibitory effects of CD40 ligand (CD154) and its endogenous expression in human breast cancer." in: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 7, Issue 3, pp. 691-703, 2001 (PubMed).
Fournier, Chalus, Durand, Garcia, Pin, Churakova, Patel, Zlot, Gorman, Zurawski, Abrams, Bates, Garrone: "FDF03, a novel inhibitory receptor of the immunoglobulin superfamily, is expressed by human dendritic and myeloid cells." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 165, Issue 3, pp. 1197-209, 2000 (PubMed).
|
